by Jason Heaviland | Aug 20, 2026
Exposomics Reveals Differential Exposures And Chemical Subgroups ow can researchers identify which environmental chemicals differ between patient groups? How do they distinguish environmental exposures from naturally occurring metabolites? And how can machine learning...
by Jason Heaviland | Aug 4, 2026
Characterizing Chemical Exposures During Pregnancy Through Targeted and Discovery Exposomics™ Exposomics provides a comprehensive approach to characterize exogenous chemical exposures during pregnancy by profiling compounds in maternal and placental samples. In this...
by Jason Heaviland | Jul 23, 2026
How Genomics and Exposomics Will Transform Precision Medicine Genomics has transformed precision medicine by revealing an individual’s genetic blueprint—but genetics alone cannot explain why people with similar genomes often experience very different health...
by Jason Heaviland | Jul 22, 2026
How Exposomics Can Improve Clinical Trials and Precision Medicine Why do promising drugs fail in Phase III clinical trials? Why do patients respond differently to the same therapy across countries? And if genetics only explains part of disease risk, what information...
by Jason Heaviland | Jul 16, 2026
How are exposure patterns linked to biological pathways? Environmental chemical exposures can significantly influence drug metabolism, therapeutic response, and disease biology—but they are often overlooked in biomedical research and clinical development.In this...
